Targeted prodrug cytosine deaminase fusion carrier and application thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10947270
APP PUB NO 20190211057A1
SERIAL NO

16247489

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a targeted prodrug enzyme fusion carrier comprising a targeted molecule and a prodrug enzyme. The targeted prodrug enzyme fusion carrier can effectively identify and bind to tumor cells and tumor-induced tumor angiogenesis. The targeted prodrug enzyme fusion carrier also has a targeted prodrug enzyme fusion protein and a theranostic system utilizing the method of in vivo nuclear medicine for the clinical diagnosis and treatment of individual patients with tumors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL YANG MING CHIAO TUNG UNIVERSITYNO 1001 DAXUE RD EAST DIST HSINCHU CITY 300

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chang, C Allen Taipei, TW 3 35
Chang, Shun-Fu Taipei, TW 3 0
Li, Jia-Je Taipei, TW 2 0
Wang, Hsin-Ell Taipei, TW 9 11
Wu, Roy Chen-Chih Taipei, TW 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 16, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 16, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00